Annual report pursuant to Section 13 and 15(d)

Note 1 - Reporting entity: (Details Textual)

v3.23.1
Note 1 - Reporting entity: (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jul. 18, 2022
Dec. 31, 2022
Dec. 31, 2021
Notes To Financial Statements [Abstract]      
Accumulated deficit   $ (464,330) $ (422,507)
Cash and investment   47,000  
Working capital   $ 37,200  
Common stock bid price per share $ 1.00    
Closing bid price requirement description   On January 18, 2023, we qualified for a 180-day extension to July 18, 2023. If we are unable to meet the minimum closing bid price requirement under Nasdaq Listing Rule 5810(c)(3)(A) by then, Nasdaq will provide notice that our securities will be subject to delisting.